Background: Despite prompt and appropriate care, Streptococcus pneumoniae (S. pneumoniae) meningitis remains a key cause of childhood morbidity and mortality. Recently, several studies suggested the possibility of microRNAs (miRNA) involvement in multiple brain and infectious diseases. This study aimed to investigate the expressional changes of brain-enriched miRNAs (124, 134, 9, and 138), and inflammation-related miRNAs (132, 181a, 221, and 222) in the cerebral cortex of acute S. pneumoniae meningitis in postnatal day 25 rats with and without treatment. Methodology: Quantitative polymerase chain reaction (qPCR) was used to measure the expression levels of the tested brain-enriched and inflammation-related miRNAs in the cerebral cortical tissues obtained from acute experimental meningitis rat model induced by intracranial inoculation of S. pneumoniae serotype 3 with and without treatment. Control rats inoculated with saline were also included. Results: Brainenriched miRNAs are significantly downregulated in untreated animals while after treatment with antibiotic and steroid for 24 hours, miR-124 and miR-9 expressions were nearly equal to the control, while miR-134 and miR-138 were significantly upregulated. Inflammation-related miR-132 was significantly downregulated in untreated and treated animals while miRNAs (181a, 221, and 222) were significantly upregulated in untreated and treated animals. Conclusion: Acute S. pneumoniae meningitis leads to significant changes in the cerebral cortical expressions of some brain-enriched and inflammation-related miRNAs. These miRNAs may play a role in the pathogenesis of acute bacterial meningitis.
Introduction
Acute bacterial meningitis (ABM) remains a potentially debilitating infection in children resulting in high mortality as well as longterm disability in up to a third of the survivors [2] [3] [4] [5] . Furthermore, dysregulation of miRNAs has been implicated in the etiology of multiple acute and chronic pediatric disorders reviewed in [6] [7] [8] .
miRNA expression is highly enriched in the nervous system with approximately 70% of experimentally detectable miRNAs expressed in the brain [9] . miRNAs are also involved in the regulation of several aspects of the innate, adaptive immune responses and inflammationrelated disorders. Studies uncovered a subset of miRNAs which are brain-enriched including miRNAs (124, 134, 9, and 138) and inflammationrelated miRNAs including (132, 181a, 221, and 222) which were extensively studied in multiple brain disease in both developing and adult brains [4, [10] [11] [12] , and also in infectious diseases [13] [14] [15] .
In light of being brain-enriched and their growing roles in the inflammation-related disorders, we hypothesize that these brain- 
Experimental procedures
Animal model preparation 
Animal model
On PN 25, the experimental and control rats were given intraperitoneal chloral hydrate 
Rat tissue preparation for RNA isolation
The rats were sacrificed under deep anesthesia by an intraperitoneal injection of chloral hydrate (10%, 5 ml/kg) 24 hours after bacterial inoculation in the untreated group and 24
hours after ceftriaxone and dexamethasone in the treated group. Control rats were also included. After decapitation, the cerebral cortex was removed quickly using RNase-free instruments. All materials were frozen on dry ice and stored at -80°C until use.
RNA isolation
For RNA isolation, frozen material was homogenized in 1 ml Trizol Reagent (Invitrogen, Carlsbad, CA, USA) for each 50 mg of hippocampal tissue. After adding 0.2 ml of chloroform, the aqueous phase was isolated using Phase Lock tubes (Eppendorf, Hamburg, Germany). RNA was precipitated with 0.5 ml isopropyl alcohol, washed twice with 75%
ethanol, and dissolved in nuclease-free water.
The concentration and purity of RNA were determined at 260/280 nm using a nanodrop spectrophotometer (Ocean Optics, Dunedin, FL, USA).
Assessment of brain-enriched miRNAs (124, 134, 9, and 138) and inflammation related miRNAs (132, 181a, 221, and 222) relative expressions
All the miRNAs primers were purchased from GeneCopoeia Company (USA). cDNA synthesis was performed using the One Step PrimeScript® 
Statistical analysis
All of the data are expressed as means ± standard deviation. A Student's t test was performed to determine significant differences between two groups. One-way analysis of variance was utilized to determine significant differences among multiple groups. P < 0.05 was considered to be statistically significant.
Results
Relative In rat tissues, miRNAs (132, 181a, 221, and 222) expressions were normalized to that of the rat U6B small nuclear RNA gene (rnu6b) (P < 0.05).
Discussion
Despite the significant advances in treatment, bacterial meningitis remains one of the most detrimental infectious diseases of the CNS with high mortality and morbidity. S. pneumoniae is one of the major causative pathogens of the most severe form of BM, in terms of mortality and morbidity [17] . A better understanding for the ABM molecular basis in the developing brains may result in strategies for the treatment of this infection.
In addition to well-established miRNA functions in a wide range of pathological and physiological process, it is becoming clear that miRNAs also play crucial roles during microbial by Angiostrongylus cantonensis [14] .
TLR4 related miR-146a was also significantly downregulated in acute Escherichia coli meningitis of immature rat models [27] . It will be interesting to determine if miR-132 downregulation plays an anti-inflammatory effect in the meningitis animal model.
Other inflammation-related miRNAs (181a, 221, and 222) were upregulated in the treated and untreated animals. In our previous work we found significant upregulation in these miRNAs expressions in the astrocytes stimulated with lipopolysaccharides (LPS) [28] and also in microglia exposed to oxygen glucose deprivation (OGD) [29] . Further experiments will need to prove if these miRNAs have a proinflammatory function or not in this animal model.
In conclusion, our study shows that S.
pneumoniae meningitis with and without treatment leads to significant changes in the expression of some brain-enriched and inflammation-related miRNAs. Modulation in the expression of these miRNAs may be a novel molecular target for S. pneumoniae bacterial meningitis treatment in developing brains.
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